Table 5.
Summary of top promising beliefs in predicting recommendation intention
| Confidence-boosting beliefs (PPG%) | Hesitancy-fanning beliefs (PPG%) | |
|---|---|---|
| Overall | Important others think I should get (17.19%) Effectiveness (17.01%) Confidence in explaining science (16.56%) Safety (16.55%) Confidence in explaining pro and con (15.97%) Help reach herd immunity (15.7%) Confidence in explaining FDA process (14.94%) Help go back to normal life (13.82%) Help protect vulnerable population (13.53%) |
Don’t know about mRNA safety yet (12.44%) The vaccine was developed faster due to political pressure (12.46%) Limited reliable information (11.93%) |
| Rural | Important others think I should get (20.48%) Safety (20.16%) Help reach herd immunity (19.46%) Effectiveness (19.41%) Confidence in explaining science (19.05%) Confidence in explaining pro and con (18.73%) Confidence in explaining FDA process (17.94%) Help go back to normal life (17.07%) Help protect vulnerable population (15.55%) |
The vaccine was developed faster due to political pressure (13.19%) Limited reliable information (12.54%) Don’t know about mRNA safety yet (12.53%) Most health professionals choose to get vaccinated (11.95%) |
| Urban | Effectiveness (14.30%) Confidence in explaining science (13.04%) Confidence in explaining pro and con (12.80%) Safety (12.36%) |
The vaccine was developed faster due to political pressure (12.31%) Conflict/contradictory information (12.07%) |
| Clinical | Confidence in explaining FDA process (13.08%) Effectiveness (12.94%) Confidence in explaining pro and con (12.59%) Safety (12.48%) Important others think I should get (12.37%) Confidence in explaining science (12.09%) |
The vaccine was developed faster due to political pressure (13.07%) |
| Non-clinical | Effectiveness (19.99%) Safety (19.71%) Confidence in explaining science (19.50%) Important others think I should get (18.78%) Help reach herd immunity (18.09%) Confidence in explaining pro and con (17.90%) Help go back to normal life (15.20%) Confidence in explaining FDA process (15.08%) Help protect vulnerable population (14.05%) |
Don’t know about mRNA safety yet (13.96%) Limited reliable information (13.74%) Approval process was too hasty (12.22%) |
Notes: top-ranked beliefs identified using a global cut-off point (PPG = 11.93%) corresponding to the 75th percentile in the distribution of PPG scores across all the beliefs in the overall sample. Outcome is recommendation intention.